Despite these limitations, to the best of our knowledge, this is the first large cohort study in a real-world setting to investigate the relationship of CD4/CD8 ratio recovery and CKD incidence in HIV-infected patients receiving ART. The gene discussed is CD8A; the disease is chronic kidney disease.